MIB-1 expression in cervical Papanicolaou tests correlates with dysplasia in subsequent cervical biopsies

Zhuowen Zeng, Giuseppe Del Priore, Jean Mark Cohen, Khush Mittal

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Ki-67 nuclear antigen is present in proliferating cells. MIB-1 antibody, raised to the recombinant part of the Ki-67 antigen, is a widely used biologic marker to assess cell proliferation. Ki-67 expression is normally observed in parabasal and basal cells in the cervix. With increasing severity of dysplasia, MIB-1 labeling is seen in cells of the superficial layers of cervical epithelium, which are exfoliated. The purpose of this study was to determine the sensitivity and specificity of presence of MIB-1-positive cells in Papanicolaou tests for predicting cervical neoplasia, condyloma, or both, on follow up. Using microwave antigen retrieval method, 49 air-dried cervical smears in two-smear cases were evaluated with immunostaining with MIB-1 monoclonal antibody. Presence of MIB-1 positivity was arbitrarily set at ≥4 MIB-1 immunoreactive cells in each smear. The degree of positive staining was correlated with the cytologic diagnoses, subsequent colposcopy-directed biopsies, endocervical curettage, and/or cytologic follow ups. Follow-up findings correlated with cytology in 33 cases (67%), with MIB-1 positivity in 35 cases (71%). Three cases with positive follow ups were missed by cytology but detected by MIB-1 staining, and three cases were missed by MIB- 1 but detected by cytology. Both cytology and MIB-1 staining failed to detect a subsequent cervical lesion in two cases, and in six cases each, an abnormal finding was not substantiated on follow ups. MIB-1 immunostaining is a powerful technique for evaluating gynecologic smears and is as equally sensitive and specific as cervical cytology. It is able to identify cervical disease overlooked by cytologic screening; therefore, it may serve as an adjunct and complimentary tool to cervical cytology.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalApplied Immunohistochemistry and Molecular Morphology
Volume10
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Papanicolaou Test
Cell Biology
Biopsy
Ki-67 Antigen
Staining and Labeling
Nuclear Antigens
Colposcopy
Vaginal Smears
Curettage
Microwaves
Cervix Uteri
Epithelium
Biomarkers
Air
Cell Proliferation
Antigens
Sensitivity and Specificity
Neoplasms

Keywords

  • Dysplasia
  • Ki-67
  • MIB-1
  • Neoplasia
  • Papanicolaou test

ASJC Scopus subject areas

  • Anatomy
  • Medical Laboratory Technology

Cite this

MIB-1 expression in cervical Papanicolaou tests correlates with dysplasia in subsequent cervical biopsies. / Zeng, Zhuowen; Del Priore, Giuseppe; Cohen, Jean Mark; Mittal, Khush.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 10, No. 1, 2002, p. 15-19.

Research output: Contribution to journalArticle

Zeng, Zhuowen ; Del Priore, Giuseppe ; Cohen, Jean Mark ; Mittal, Khush. / MIB-1 expression in cervical Papanicolaou tests correlates with dysplasia in subsequent cervical biopsies. In: Applied Immunohistochemistry and Molecular Morphology. 2002 ; Vol. 10, No. 1. pp. 15-19.
@article{1243daea60854d7e8c51286b1185cc93,
title = "MIB-1 expression in cervical Papanicolaou tests correlates with dysplasia in subsequent cervical biopsies",
abstract = "Ki-67 nuclear antigen is present in proliferating cells. MIB-1 antibody, raised to the recombinant part of the Ki-67 antigen, is a widely used biologic marker to assess cell proliferation. Ki-67 expression is normally observed in parabasal and basal cells in the cervix. With increasing severity of dysplasia, MIB-1 labeling is seen in cells of the superficial layers of cervical epithelium, which are exfoliated. The purpose of this study was to determine the sensitivity and specificity of presence of MIB-1-positive cells in Papanicolaou tests for predicting cervical neoplasia, condyloma, or both, on follow up. Using microwave antigen retrieval method, 49 air-dried cervical smears in two-smear cases were evaluated with immunostaining with MIB-1 monoclonal antibody. Presence of MIB-1 positivity was arbitrarily set at ≥4 MIB-1 immunoreactive cells in each smear. The degree of positive staining was correlated with the cytologic diagnoses, subsequent colposcopy-directed biopsies, endocervical curettage, and/or cytologic follow ups. Follow-up findings correlated with cytology in 33 cases (67{\%}), with MIB-1 positivity in 35 cases (71{\%}). Three cases with positive follow ups were missed by cytology but detected by MIB-1 staining, and three cases were missed by MIB- 1 but detected by cytology. Both cytology and MIB-1 staining failed to detect a subsequent cervical lesion in two cases, and in six cases each, an abnormal finding was not substantiated on follow ups. MIB-1 immunostaining is a powerful technique for evaluating gynecologic smears and is as equally sensitive and specific as cervical cytology. It is able to identify cervical disease overlooked by cytologic screening; therefore, it may serve as an adjunct and complimentary tool to cervical cytology.",
keywords = "Dysplasia, Ki-67, MIB-1, Neoplasia, Papanicolaou test",
author = "Zhuowen Zeng and {Del Priore}, Giuseppe and Cohen, {Jean Mark} and Khush Mittal",
year = "2002",
doi = "10.1097/00022744-200203000-00003",
language = "English (US)",
volume = "10",
pages = "15--19",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - MIB-1 expression in cervical Papanicolaou tests correlates with dysplasia in subsequent cervical biopsies

AU - Zeng, Zhuowen

AU - Del Priore, Giuseppe

AU - Cohen, Jean Mark

AU - Mittal, Khush

PY - 2002

Y1 - 2002

N2 - Ki-67 nuclear antigen is present in proliferating cells. MIB-1 antibody, raised to the recombinant part of the Ki-67 antigen, is a widely used biologic marker to assess cell proliferation. Ki-67 expression is normally observed in parabasal and basal cells in the cervix. With increasing severity of dysplasia, MIB-1 labeling is seen in cells of the superficial layers of cervical epithelium, which are exfoliated. The purpose of this study was to determine the sensitivity and specificity of presence of MIB-1-positive cells in Papanicolaou tests for predicting cervical neoplasia, condyloma, or both, on follow up. Using microwave antigen retrieval method, 49 air-dried cervical smears in two-smear cases were evaluated with immunostaining with MIB-1 monoclonal antibody. Presence of MIB-1 positivity was arbitrarily set at ≥4 MIB-1 immunoreactive cells in each smear. The degree of positive staining was correlated with the cytologic diagnoses, subsequent colposcopy-directed biopsies, endocervical curettage, and/or cytologic follow ups. Follow-up findings correlated with cytology in 33 cases (67%), with MIB-1 positivity in 35 cases (71%). Three cases with positive follow ups were missed by cytology but detected by MIB-1 staining, and three cases were missed by MIB- 1 but detected by cytology. Both cytology and MIB-1 staining failed to detect a subsequent cervical lesion in two cases, and in six cases each, an abnormal finding was not substantiated on follow ups. MIB-1 immunostaining is a powerful technique for evaluating gynecologic smears and is as equally sensitive and specific as cervical cytology. It is able to identify cervical disease overlooked by cytologic screening; therefore, it may serve as an adjunct and complimentary tool to cervical cytology.

AB - Ki-67 nuclear antigen is present in proliferating cells. MIB-1 antibody, raised to the recombinant part of the Ki-67 antigen, is a widely used biologic marker to assess cell proliferation. Ki-67 expression is normally observed in parabasal and basal cells in the cervix. With increasing severity of dysplasia, MIB-1 labeling is seen in cells of the superficial layers of cervical epithelium, which are exfoliated. The purpose of this study was to determine the sensitivity and specificity of presence of MIB-1-positive cells in Papanicolaou tests for predicting cervical neoplasia, condyloma, or both, on follow up. Using microwave antigen retrieval method, 49 air-dried cervical smears in two-smear cases were evaluated with immunostaining with MIB-1 monoclonal antibody. Presence of MIB-1 positivity was arbitrarily set at ≥4 MIB-1 immunoreactive cells in each smear. The degree of positive staining was correlated with the cytologic diagnoses, subsequent colposcopy-directed biopsies, endocervical curettage, and/or cytologic follow ups. Follow-up findings correlated with cytology in 33 cases (67%), with MIB-1 positivity in 35 cases (71%). Three cases with positive follow ups were missed by cytology but detected by MIB-1 staining, and three cases were missed by MIB- 1 but detected by cytology. Both cytology and MIB-1 staining failed to detect a subsequent cervical lesion in two cases, and in six cases each, an abnormal finding was not substantiated on follow ups. MIB-1 immunostaining is a powerful technique for evaluating gynecologic smears and is as equally sensitive and specific as cervical cytology. It is able to identify cervical disease overlooked by cytologic screening; therefore, it may serve as an adjunct and complimentary tool to cervical cytology.

KW - Dysplasia

KW - Ki-67

KW - MIB-1

KW - Neoplasia

KW - Papanicolaou test

UR - http://www.scopus.com/inward/record.url?scp=0036181451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036181451&partnerID=8YFLogxK

U2 - 10.1097/00022744-200203000-00003

DO - 10.1097/00022744-200203000-00003

M3 - Article

VL - 10

SP - 15

EP - 19

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 1

ER -